These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8801857)

  • 21. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A: infection, detection, vaccination and immunity.
    van Hattum J; Chen XQ
    Neth J Med; 1999 Sep; 55(3):142-50. PubMed ID: 10509073
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis A vaccination.
    Thiel TK
    Am Fam Physician; 1998 Apr; 57(7):1500. PubMed ID: 9556642
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis A vaccine for secondary hepatitis A infection.
    Shouval D; Ashur Y
    Lancet; 1999 Jul; 354(9175):342-3. PubMed ID: 10440345
    [No Abstract]   [Full Text] [Related]  

  • 25. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.
    Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes ahead in childhood immunization.
    Marwick C
    JAMA; 1996 Feb; 275(8):582. PubMed ID: 8594229
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis A updated.
    Yap I
    Singapore Med J; 1995 Feb; 36(1):23-4. PubMed ID: 7570128
    [No Abstract]   [Full Text] [Related]  

  • 31. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supplementary statement on hepatitis A prevention. Laboratory Centre for Disease Control.
    CMAJ; 1996 Aug; 155(3):302-5. PubMed ID: 8705911
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response.
    Bienzle U; Bock HL; Kruppenbacher JP; Hofmann F; Vogel GE; Clemens R
    Vaccine; 1996 Apr; 14(6):501-5. PubMed ID: 8782347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protection of adolescents against hepatitis A].
    Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
    Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule.
    Westblom TU; Gudipati S; DeRousse C; Midkiff BR; Belshe RB
    J Infect Dis; 1994 May; 169(5):996-1001. PubMed ID: 8169430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vacillate or vaccinate.
    Bednarsh H
    Dent Assist; 1995 Oct; 64(4):6-7. PubMed ID: 9525123
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vaccination against hepatitis A].
    Germanaud J; Causse X
    Servir; 1994; 42(3):161-4. PubMed ID: 8059246
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis A vaccination programs in communities with high rates of hepatitis A.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(26):600-3. PubMed ID: 9221328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.